NSE · Healthcare · Drug Manufacturers - Specialty & Generic
| Document | Date |
|---|---|
| Quarterly results · Q1 FY27 SYNCOM FORMULATIONS (INDIA) LIMITED Q1 FY2026-27 FINANCIAL RESULTS SUMMARY --- HEADLINE NUMBERS • Q1 FY2026-27 Standalone Revenue from Operations: | 2026-08-11 |
| Quarterly results · Q4 FY26 SYNCOM FORMULATIONS (INDIA) LIMITED - FINANCIAL SUMMARY HEADLINE NUMBERS • FY 2025-26 Revenue from Operations: Rs 48,657.28 lacs (up from Rs 46,284. | 2026-05-22 |
| Quarterly results · Q3 FY26 SYNCOM FORMULATIONS (INDIA) LIMITED – FINANCIAL SUMMARY 9 Months ended 31st December 2025 --- HEADLINE NUMBERS • Revenue from Operations (9M FY26): | 2026-02-12 |
| Quarterly results · Q2 FY26 SYNCOM FORMULATIONS (INDIA) LIMITED - H1 FY2025-26 FINANCIAL SUMMARY HEADLINE NUMBERS • Q2 FY2025-26 Revenue from Operations: Rs 12,143.51 lakhs (St | 2025-11-12 |
| Annual report FY2025 SYNCOM FORMULATIONS (INDIA) LIMITED – ANNUAL REPORT 2024-25 SUMMARY HEADLINE NUMBERS • Company: Syncom Formulations (India) Limited – pharmaceutical | 2025-09-04 |
| Quarterly results · Q1 FY26 SYNCOM FORMULATIONS (INDIA) LIMITED – Q1 FY2025-26 FINANCIAL SUMMARY HEADLINE NUMBERS • Q1 FY2025-26 (Quarter ended 30 June 2025) Standalone Results | 2025-08-08 |
| Quarterly results | 2025-02-10 |
| Quarterly results | 2024-11-11 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Syncom Formulations (India) Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.